A Hib-DTP-hepatitis B vaccine [Quinvaxem; Berna Biotech, Chiron Corporation] has been awarded licensure by the Korea Food and Drug Administration

Source: Inpharma, Volume 1, Number 1531, 2006-04-01 , pp. 18-18(1)

Price: $37.95 plus tax (Refund Policy)

Keywords: Children; Development-status; Diphtheria, prevention; Haemophilus-infections, prevention; Hepatitis-B, prevention; Hib-DTP-hepatitis-B-vaccine, immunogenicity; Pertussis, prevention; Product-approvals; Product-launches; Tetanus, prevention; Vaccines, immunogenicity

Document Type: Short communication

Publication date: 2006-01-01

Free content

New content

Open access content

Subscribed content

Free trial content

Here are a few pages on the site that we think you may find useful:

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.